Log in | Register

Agencies and Organizations

Chelsea Therapeutics Sees Possible Northera Delay

2 hours ago | News

CHARLOTTE, N.C. (AP) — Chelsea Therapeutics International Ltd. said Tuesday it may have to make changes to a clinical trial of its drug candidate Northera, potentially delaying its approval.  

Launch of book on Lee Jong-Wook, former Director General of WHO

15 hours ago | News

On the sixth anniversary of the death of the former Director General of the...

Panel discusses how to incorporate gender equity and human rights in health care reform

23 hours ago | News

The integration of gender equity and human rights in health policies and programs was...

NHGRI collaborates with Smithsonian to produce new genome exhibit

May 22 | News

To celebrate the 10th anniversary of the completion of the first complete human genome sequence -- the genetic blueprint of the human body -- the Smithsonian Institution will open a high-tech, high-intensity exhibit in 2013. The exhibit is a collaboration of the Smithsonian's National...

NIH study shows poor quality malaria drugs pose threat

May 22 | News

Poor quality antimalarial drugs lead to drug resistance and inadequate treatment that pose an urgent threat to vulnerable populations, according to a National Institutes of Health study published May 22 in The Lancet Infectious Diseasesjournal. Emergence of malaria strains that are...

FDA Says Xarelto Reduced Deadly Heart Attacks

May 22 | News

WASHINGTON (AP) — The Food and Drug Administration said Monday that a blood thinner from Johnson & Johnson appears to reduce life-threatening blood clots in high-risk patients, although it also increases the risk of internal bleeding.  

Final Advice: Panel Against Routine Prostate Test

May 22 | News

WASHINGTON (AP) — Healthy men shouldn't get routine prostate cancer screenings, says updated advice from a government panel that found the PSA blood tests do more harm than good.  

Harper Government leads an international roundtable on mental health

May 22 | News

The Honourable Leona Aglukkaq, Minister of Health, today led an international roundtable to discuss common challenges and promising practices in addressing mental health issues.

Medivation and Astellas Announce Submission of Prostate Cancer NDA

May 22 | News

Medivation, Inc. and Astellas Pharma Inc. announced that Medivation has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for enzalutamide (formerly MDV3100). The compound has been studied in patients with castration-resistant prostate cancer who have received docetaxel therapy.  

Diamond Pet Foods Expands Voluntary Recall Diamond Naturals Small Breed Adult Dog Lamb & Rice Formula Dry Dog Food Production Code DSL 0801 Due to Small Potential for Salmonel...

May 21 | News

Diamond Pet Foods is expanding a voluntary recall to include its Diamond Naturals Small Breed Adult Dog Lamb & Rice Formula dry dog food manufactured on Aug. 26, 2011 due to potential exposure to Salmonella. No illnesses have been reported.

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter